HRP20110666T1 - Uporaba 4-ciklopropilmetoksi-n-(3,5-diklor-1-oksidopiridin-4-il)-5-(metoksi)piridin-2-karboksamida u liječenju motoričkih poremećaja povezanih s parkinsonovom bolesti - Google Patents

Uporaba 4-ciklopropilmetoksi-n-(3,5-diklor-1-oksidopiridin-4-il)-5-(metoksi)piridin-2-karboksamida u liječenju motoričkih poremećaja povezanih s parkinsonovom bolesti Download PDF

Info

Publication number
HRP20110666T1
HRP20110666T1 HR20110666T HRP20110666T HRP20110666T1 HR P20110666 T1 HRP20110666 T1 HR P20110666T1 HR 20110666 T HR20110666 T HR 20110666T HR P20110666 T HRP20110666 T HR P20110666T HR P20110666 T1 HRP20110666 T1 HR P20110666T1
Authority
HR
Croatia
Prior art keywords
oxidopyridin
carboxamide
use according
disorders
cyclopropylmethoxy
Prior art date
Application number
HR20110666T
Other languages
English (en)
Croatian (hr)
Inventor
Delay-Goyet Philippe
Delgorge Claire
Menet Christine
Poughon Gilles
Ravinet-Trillou Christine
Original Assignee
Sanofi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi filed Critical Sanofi
Publication of HRP20110666T1 publication Critical patent/HRP20110666T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
HR20110666T 2007-04-19 2008-04-16 Uporaba 4-ciklopropilmetoksi-n-(3,5-diklor-1-oksidopiridin-4-il)-5-(metoksi)piridin-2-karboksamida u liječenju motoričkih poremećaja povezanih s parkinsonovom bolesti HRP20110666T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0702853A FR2915100B1 (fr) 2007-04-19 2007-04-19 Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxalide pour le traitement des desordres moteurs lies a la maladie de parkinson
PCT/FR2008/000534 WO2008145841A1 (fr) 2007-04-19 2008-04-16 Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1 -oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des desordres moteurs lies a la maladie de parkinson

Publications (1)

Publication Number Publication Date
HRP20110666T1 true HRP20110666T1 (hr) 2011-10-31

Family

ID=38712405

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20110666T HRP20110666T1 (hr) 2007-04-19 2008-04-16 Uporaba 4-ciklopropilmetoksi-n-(3,5-diklor-1-oksidopiridin-4-il)-5-(metoksi)piridin-2-karboksamida u liječenju motoričkih poremećaja povezanih s parkinsonovom bolesti

Country Status (33)

Country Link
US (1) US20100130554A1 (enExample)
EP (1) EP2146714B1 (enExample)
JP (1) JP5386478B2 (enExample)
KR (2) KR101503942B1 (enExample)
CN (1) CN101663035B (enExample)
AR (1) AR066108A1 (enExample)
AT (1) ATE513548T1 (enExample)
AU (1) AU2008257322B2 (enExample)
BR (1) BRPI0810444A2 (enExample)
CA (1) CA2684174C (enExample)
CL (1) CL2008001136A1 (enExample)
CY (1) CY1111840T1 (enExample)
DK (1) DK2146714T3 (enExample)
EA (1) EA019194B1 (enExample)
ES (1) ES2367408T3 (enExample)
FR (1) FR2915100B1 (enExample)
HR (1) HRP20110666T1 (enExample)
IL (1) IL201448A (enExample)
JO (1) JO2678B1 (enExample)
MA (1) MA31367B1 (enExample)
ME (1) ME00935B (enExample)
MX (1) MX2009011284A (enExample)
MY (1) MY148092A (enExample)
NZ (1) NZ580482A (enExample)
PA (1) PA8776801A1 (enExample)
PL (1) PL2146714T3 (enExample)
PT (1) PT2146714E (enExample)
RS (1) RS51869B (enExample)
SI (1) SI2146714T1 (enExample)
TW (1) TWI439269B (enExample)
UY (1) UY31035A1 (enExample)
WO (1) WO2008145841A1 (enExample)
ZA (1) ZA200907251B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2935219A1 (en) * 2012-11-28 2015-10-28 Sanofi METHOD OF PREPARATION OF CRYSTAL FORMS OF 4-(CYCLOPROPYLMETHOXY)-N-(3,5-DICHLORO-1-OXIDOPYRIDYN-4-yl)-5-METHOXYPYRIDINE-2-CARBOXAMIDE AND CRISTAL FORMS THEREOF
US9624100B2 (en) 2014-06-12 2017-04-18 Apple Inc. Micro pick up array pivot mount with integrated strain sensing elements
WO2025079694A1 (ja) * 2023-10-12 2025-04-17 株式会社 メドレックス 経皮吸収組成物
WO2025080415A1 (en) * 2023-10-12 2025-04-17 Alto Neuroscience, Inc. Treatment of neuropsychiatric disorders with tilivapram

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4193926A (en) * 1974-03-20 1980-03-18 Schering Aktiengesellschaft 4-(Polyalkoxy phenyl)-2-pyrrolidones
WO1995004045A1 (en) * 1993-07-28 1995-02-09 Rhone-Poulenc Rorer Limited Compounds as pde iv and tnf inhibitors
US6177077B1 (en) * 1999-02-24 2001-01-23 Edward L. Tobinick TNT inhibitors for the treatment of neurological disorders
PT1244649E (pt) * 1999-12-23 2005-06-30 Icos Corp Inibidores de fosfodiesterase especificos de mfa ciclica
WO2002069905A2 (en) * 2001-03-02 2002-09-12 Bristol-Myers Squibb Company Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders
WO2004005258A1 (en) * 2002-07-02 2004-01-15 Merck Frosst Canada & Co. Di-aryl-substituted-ethane pyridone pde4 inhibitors
DE602004032522D1 (de) * 2003-03-12 2011-06-16 Celgene Corp Mit n-alkylhydroxamsäuren substituierte isoindolylverbindungen und deren pharmazeutische verwendung
WO2006135828A2 (en) * 2005-06-10 2006-12-21 Memory Pharmaceuticals Corporation Trisubstituted amines as phosphodiesterase 4 inhibitors
US20070021451A1 (en) * 2005-07-20 2007-01-25 Hamamatsu University School Of Medicine Method for preventing or treating neurologic damage after spinal cord injury

Also Published As

Publication number Publication date
UY31035A1 (es) 2008-11-28
KR20150004885A (ko) 2015-01-13
MY148092A (en) 2013-02-28
EA200970970A1 (ru) 2010-02-26
AU2008257322A1 (en) 2008-12-04
NZ580482A (en) 2011-10-28
MX2009011284A (es) 2009-11-02
EP2146714B1 (fr) 2011-06-22
SI2146714T1 (sl) 2011-10-28
JP2010524906A (ja) 2010-07-22
KR101503942B1 (ko) 2015-03-18
AU2008257322B2 (en) 2013-06-13
ES2367408T3 (es) 2011-11-03
PL2146714T3 (pl) 2011-10-31
EA019194B1 (ru) 2014-01-30
TW200911247A (en) 2009-03-16
US20100130554A1 (en) 2010-05-27
IL201448A (en) 2014-08-31
AR066108A1 (es) 2009-07-22
EP2146714A1 (fr) 2010-01-27
IL201448A0 (en) 2010-05-31
KR20090130059A (ko) 2009-12-17
PA8776801A1 (es) 2008-11-19
PT2146714E (pt) 2011-09-02
CL2008001136A1 (es) 2009-01-16
DK2146714T3 (da) 2011-10-10
CY1111840T1 (el) 2015-10-07
ATE513548T1 (de) 2011-07-15
JO2678B1 (en) 2013-03-03
CA2684174C (fr) 2014-02-25
HK1141725A1 (en) 2010-11-19
ME00935B (me) 2012-06-20
WO2008145841A1 (fr) 2008-12-04
MA31367B1 (fr) 2010-05-03
BRPI0810444A2 (pt) 2016-05-31
FR2915100B1 (fr) 2009-06-05
ZA200907251B (en) 2011-04-28
CA2684174A1 (fr) 2008-12-04
RS51869B (sr) 2012-02-29
FR2915100A1 (fr) 2008-10-24
JP5386478B2 (ja) 2014-01-15
TWI439269B (zh) 2014-06-01
CN101663035A (zh) 2010-03-03
CN101663035B (zh) 2012-06-20

Similar Documents

Publication Publication Date Title
EA201170018A1 (ru) Разагилин для изменения течения болезни паркинсона
MX2009012485A (es) Formulacion oral de nicotina amortiguada con aminoacidos.
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
JP2019524856A5 (enExample)
WO2013049751A3 (en) Methods and oral orthotic systems for use in connection with sleep - disordered breathing
TW200738242A (en) Dihydropteridinones in the treatment of respiratory diseases
FI3504187T3 (fi) Pridopidiinin käyttö toiminnallisen heikkenemisen hoitoa varten
UA99309C2 (ru) Замещенные пиперидинодигидротиенопиримидины
EP4295909A3 (en) Carbidopa and l-dopa prodrugs and methods of use
JP2015057451A5 (enExample)
NZ595046A (en) Compositions and methods for extended therapy with aminopyridines
HRP20110666T1 (hr) Uporaba 4-ciklopropilmetoksi-n-(3,5-diklor-1-oksidopiridin-4-il)-5-(metoksi)piridin-2-karboksamida u liječenju motoričkih poremećaja povezanih s parkinsonovom bolesti
JP2012517449A5 (enExample)
NZ605469A (en) Nalbuphine-based formulations and uses thereof
UA113962C2 (xx) Фармацевтична композиція, яка містить апоморфін як активний інгредієнт
PE20081106A1 (es) Comprimidos pediatricos de capecitabina
HRP20230070T1 (hr) Tasimelteon za liječenje smith-magenis sindroma
JP2011515470A5 (enExample)
HRP20130205T1 (hr) Sastavi koji sadrže apoekvorin i postupci njihove uporabe
MX340564B (es) Isoformas de neurregulina solubles activas modificadas post-traduccionalmente.
EA201390181A1 (ru) Несущий корпус для лекарственного средства и способ его изготовления
RU2007122391A (ru) S-миртазапин для лечения приливов
CN103349585B (zh) 磁力阻鼾器及其制造方法
JP2010524906A5 (enExample)
WO2015103288A3 (en) Oral exercise appliance